Mail

UK markets close in 7 hours 13 minutes

FTSE 100
8,197.26
+25.11(+0.31%)
FTSE 250
20,068.08
+15.75(+0.08%)
AIM
769.70
+1.59(+0.21%)
GBP/EUR
1.1687
+0.0005(+0.04%)
GBP/USD
1.2556
+0.0023(+0.18%)
Bitcoin GBP
47,191.50
+1,183.41(+2.57%)

11 fabulous farmhouses perfect for a living a rural lifestyle

A farmhouse could be your dream home if you’re in search of bucolic bliss

Astellas Pharma Inc. (4503.T)

Tokyo - Tokyo Delayed price. Currency in JPY

Add to watchlist

1,558.00

+33.00

(+2.16%)

At close: 03:15PM JST

Currency in JPY

Valuation measures⁴

Market cap (intra-day)	2.79T
Enterprise value	3.38T
Trailing P/E	587.92
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.82
Price/book (mrq)	1.86
Enterprise value/revenue	2.19
Enterprise value/EBITDA	20.13

Trading information

Stock price history

Beta (5Y monthly)	0.29
52-week change ³	-25.10%
S&P500 52-week change ³	21.33%
52-week high ³	2,360.50
52-week low ³	1,426.00
50-day moving average ³	1,594.18
200-day moving average ³	1,833.66

Share statistics

Avg vol (3-month) ³	9.33M
Avg vol (10-day) ³	8.79M
Shares outstanding ⁵	1.79B
Implied shares outstanding ⁶	1.81B
Float ⁸	1.79B
% held by insiders ¹	0.25%
% held by institutions ¹	50.98%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	74
Forward annual dividend yield ⁴	4.75%
Trailing annual dividend rate ³	70.00
Trailing annual dividend yield ³	4.59%
5-year average dividend yield ⁴	2.68
Payout ratio ⁴	2,452.83%
Dividend date ³	N/A
Ex-dividend date ⁴	27 Sept 2024
Last split factor ²	5:1
Last split date ³	27 Mar 2014

Financial highlights

Fiscal year

Fiscal year ends	31 Mar 2024
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	1.06%
Operating margin (ttm)	-7.98%

Management effectiveness

Return on assets (ttm)	1.80%
Return on equity (ttm)	1.10%

Income statement

Revenue (ttm)	1.6T
Revenue per share (ttm)	894.27
Quarterly revenue growth (yoy)	17.00%
Gross profit (ttm)	N/A
EBITDA	244.7B
Net income avi to common (ttm)	17.05B
Diluted EPS (ttm)	2.65
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	335.69B
Total cash per share (mrq)	187.23
Total debt (mrq)	920.02B
Total debt/equity (mrq)	57.65%
Current ratio (mrq)	0.93
Book value per share (mrq)	890.18

Cash flow statement

Operating cash flow (ttm)	172.48B
Levered free cash flow (ttm)	109.61B